MME and Alzheimer disease: A 24-residue peptide, humanin, originally isolated from the brain of an AD patient, which has neuroprotective properties and decreases brain Aβ levels in animal models, was shown to mediate its Aβ-lowering effects by increasing NEP expression levels and could also provide a strategy for enhancing amyloid clearance [117].